Nodal enhances the activity of foxO3a and its synergistic interaction with smads to regulate cyclin G2 transcription in ovarian cancer cells

Oncogene

Volumn 30, Issue 37, 2011, Pages 3953-3966

  Fu, G ^a   Peng, C ^a  

^a YORK UNIVERSITY   (Canada)

Author keywords

ALK7; cyclin G2; FoxO3a; Nodal; ovarian cancer; Smad

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXY 1 METHYLTETRALIN; ACTIVIN RECEPTOR LIKE KINASE 7; CYCLIN G2; MESSENGER RNA; NODAL SIGNALING PROTEIN; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR FKHRL1; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; FEMALE; GENE DELETION; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION REGULATION; UPREGULATION;

ACTIVIN RECEPTORS, TYPE I; ADENOCARCINOMA; BINDING SITES; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN G2; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; MUTATION; NODAL PROTEIN; ONCOGENE PROTEIN V-AKT; OVARIAN NEOPLASMS; PROMOTER REGIONS, GENETIC; SMAD PROTEINS;

EID: 80052730839     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.127     Document Type: Article

References (62)

1. Accili D, Arden KC. (2004). FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 117: 421-426. (Pubitemid 38610228)
2. Adorno M, Cordenonsi M, Montagner M, Dupont S, Wong C, Hann B et al. (2009). A Mutant-p53/Smad complex opposes p63 to empower TGFbeta-induced metastasis. Cell 137: 87-98.
3. Anderson MJ, Viars CS, Czekay S, Cavenee WK, Arden KC. (1998). Cloning and characterization of three human forkhead genes that comprise an FKHR-like gene subfamily. Genomics 47: 187-199. (Pubitemid 28086844)
4. Baker K, Holtzman NG, Burdine RD. (2008). Direct and indirect roles for Nodal signaling in two axis conversions during asymmetric morphogenesis of the zebrafish heart. Proc Natl Acad Sci USA 105: 13924-13929.
5. Bates S, Rowan S, Vousden KH. (1996). Characterisation of human cyclin G1 and G2: DNA damage inducible genes. Oncogene 13: 1103-1109. (Pubitemid 26329098)
6. Bennin DA, Don AS, Brake T, McKenzie JL, Rosenbaum H, Ortiz L et al. (2002). Cyclin G2 associates with protein phosphatase 2A catalytic and regulatory B' subunits in active complexes and induces nuclear aberrations and a G1/S phase cell cycle arrest. J Biol Chem 277: 27449-27467. (Pubitemid 34951766)
7. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS et al. (1999). Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96: 857-868. (Pubitemid 29165088)
8. Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y et al. (2004). Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303: 2011-2015. (Pubitemid 38393275)
9. Chen J, Yusuf I, Andersen HM, Fruman DA. (2006). FOXO transcription factors cooperate with delta EF1 to activate growth suppressive genes in B lymphocytes. J Immunol 176: 2711-2721.
10. Cornforth AN, Davis JS, Khanifar E, Nastiuk KL, Krolewski JJ. (2008). FOXO3a mediates the androgen-dependent regulation of FLIP and contributes to TRAIL-induced apoptosis of LNCaP cells. Oncogene 27: 4422-4433.
11. Derynck R, Akhurst RJ, Balmain A. (2001). TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 29: 117-129. (Pubitemid 32952643)
12. Derynck R, Zhang YE. (2003). Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425: 577-584. (Pubitemid 37280136)
13. Dijkers PF, Medema RH, Pals C, Banerji L, Thomas NS, Lam EW et al. (2000). Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27(KIP1). Mol Cell Biol 20: 9138-9148. (Pubitemid 32246103)
14. Fei M, Zhao Y, Wang Y, Lu M, Cheng C, Huang X et al. (2009). Low expression of Foxo3a is associated with poor prognosis in ovarian cancer patients. Cancer Invest 27: 52-59.
15. Fernandez de Mattos S, Essafi A, Soeiro I, Pietersen AM, Birkenkamp KU, Edwards CS et al. (2004). FoxO3a and BCR-ABL regulate cyclin D2 transcription through a STAT5/BCL6-dependent mechanism. Mol Cell Biol 24: 10058-10071. (Pubitemid 39458829)
16. Furuyama T, Nakazawa T, Nakano I, Mori N. (2000). Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues. Biochem J 349: 629-634. (Pubitemid 30465799)
17. Gomis RR, Alarcon C, He W, Wang Q, Seoane J, Lash A et al. (2006a). A FoxO-Smad synexpression group in human keratino-cytes. Proc Natl Acad Sci USA 103: 12747-12752. (Pubitemid 44298632)
18. Gomis RR, Alarcon C, Nadal C, Van Poznak C, Massague J. (2006b). C/EBPbeta at the core of the TGFbeta cytostatic response and its evasion in metastatic breast cancer cells. Cancer Cell 10: 203-214. (Pubitemid 44311064)
19. Hauck L, Harms C, Grothe D, An J, Gertz K, Kronenberg G et al. (2007). Critical role for FoxO3a-dependent regulation of p21CIP1/WAF1 in response to statin signaling in cardiac myocytes. Circ Res 100: 50-60. (Pubitemid 46066773)
20. Horne MC, Donaldson KL, Goolsby GL, Tran D, Mulheisen M, Hell JW et al. (1997). Cyclin G2 is up-regulated during growth inhibition and B cell antigen receptor-mediated cell cycle arrest. J Biol Chem 272: 12650-12661. (Pubitemid 27203362)
21. Horne MC, Goolsby GL, Donaldson KL, Tran D, Neubauer M, Wahl AF. (1996). Cyclin G1 and cyclin G2 comprise a new family of cyclins with contrasting tissue-specific and cell cycle-regulated expression. J Biol Chem 271: 6050-6061. (Pubitemid 26095408)
22. Hu MC, Lee DF, Xia W, Golfman LS, Ou-Yang F, Yang JY et al. (2004). IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 117: 225-237. (Pubitemid 38496242)
23. Huang H, Tindall DJ. (2007). Dynamic FoxO transcription factors. J Cell Sci 120: 2479-2487. (Pubitemid 47323857)
24. Katayama K, Nakamura A, Sugimoto Y, Tsuruo T, Fujita N. (2008). FOXO transcription factor-dependent p15(INK4b) and p19(INK4d) expression. Oncogene 27: 1677-1686. (Pubitemid 351380267)
25. Kenney NJ, Adkins HB, Sanicola M. (2004). Nodal and Cripto-1: embryonic pattern formation genes involved in mammary gland development and tumorigenesis. J Mammary Gland Biol Neoplasia 9: 133-144. (Pubitemid 39177499)
26. Kim Y, Shintani S, Kohno Y, Zhang R, Wong DT. (2004). Cyclin G2 dysregulation in human oral cancer. Cancer Res 64: 8980-8986. (Pubitemid 39665507)
27. Kops GJ, de Ruiter ND, De Vries-Smits AM, Powell DR, Bos JL, Burgering BM. (1999). Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature 398: 630-634. (Pubitemid 29183692)
28. Kumar A, Novoselov V, Celeste AJ, Wolfman NM, Ten Dijke P, Kuehn MR. (2001). Nodal signaling uses activin and transforming growth factor-beta receptor-regulated Smads. J Biol Chem 276: 656-661. (Pubitemid 32050362)
29. Le XF, Arachchige-Don AS, Mao W, Horne MC, Bast Jr RC. (2007). Roles of human epidermal growth factor receptor 2, c-jun NH2-terminal kinase, phosphoinositide 3-kinase, and p70 S6 kinase pathways in regulation of cyclin G2 expression in human breast cancer cells. Mol Cancer Ther 6: 2843-2857. (Pubitemid 350214268)
30. 0-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells. J Biol Chem 282: 21542-21550. (Pubitemid 47099972)
31. Lin K, Dorman JB, Rodan A, Kenyon C. (1997). daf-16: an HNF-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans. Science 278: 1319-1322. (Pubitemid 27495748)
32. Marshall GM, Gherardi S, Xu N, Neiron Z, Trahair T, Scarlett CJ et al. (2010). Transcriptional upregulation of histone deacetylase 2 promotes Myc-induced oncogenic effects. Oncogene 29: 5957-5968.
33. Martinez-Gac L, Marques M, Garcia Z, Campanero MR, Carrera AC. (2004). Control of cyclin G2 mRNA expression by forkhead transcription factors: novel mechanism for cell cycle control by phosphoinositide 3-kinase and forkhead. Mol Cell Biol 24: 2181-2189. (Pubitemid 38248955)
34. Massague J, Seoane J, Wotton D. (2005). Smad transcription factors. Genes Dev 19: 2783-2810. (Pubitemid 41739965)
35. Matsuyama S, Iwadate M, Kondo M, Saitoh M, Hanyu A, Shimizu K et al. (2003). SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells. Cancer Res 63: 7791-7798. (Pubitemid 37466711)
36. Munir S, Xu G, Wu Y, Yang B, Lala PK, Peng C. (2004). Nodal and ALK7 inhibit proliferation and induce apoptosis in human trophoblast cells. J Biol Chem 279: 31277-31286. (Pubitemid 39037793)
37. Naora H, Montell DJ. (2005). Ovarian cancer metastasis: integrating insights from disparate model organisms. Nat Rev Cancer 5: 355-366. (Pubitemid 40637827)
38. Ogawa K, Saito A, Matsui H, Suzuki H, Ohtsuka S, Shimosato D et al. (2007). Activin-nodal signaling is involved in propagation of mouse embryonic stem cells. J Cell Sci 120: 55-65. (Pubitemid 46206649)
39. Papageorgiou I, Nicholls PK, Wang F, Lackmann M, Makanji Y, Salamonsen LA et al. (2009). Expression of nodal signalling components in cycling human endometrium and in endometrial cancer. Reprod Biol Endocrinol 7: 122.
40. Ramaswamy S, Nakamura N, Sansal I, Bergeron L, Sellers WR. (2002). A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR. Cancer Cell 2: 81-91. (Pubitemid 41043990)
41. Reissmann E, Jornvall H, Blokzijl A, Andersson O, Chang C, Minchiotti G et al. (2001). The orphan receptor ALK7 and the Activin receptor ALK4 mediate signaling by Nodal proteins during vertebrate development. Genes Dev 15: 2010-2022. (Pubitemid 32738629)
42. Schier AF. (2003). Nodal signaling in vertebrate development. Annu Rev Cell Dev Biol 19: 589-621. (Pubitemid 37487362)
43. Schier AF, Shen MM. (2000). Nodal signalling in vertebrate development. Nature 403: 385-389. (Pubitemid 30073079)
44. Seoane J, Le HV, Shen L, Anderson SA, Massague J. (2004). Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 117: 211-223. (Pubitemid 38496241)
45. Shen MM. (2007). Nodal signaling: developmental roles and regulation. Development 134: 1023-1034. (Pubitemid 46630070)
46. Stossi F, Likhite VS, Katzenellenbogen JA, Katzenellenbogen BS. (2006). Estrogen-occupied estrogen receptor represses cyclin G2 gene expression and recruits a repressor complex at the cyclin G2 promoter. J Biol Chem 281: 16272-16278.
47. Strizzi L, Postovit LM, Margaryan NV, Seftor EA, Abbott DE, Seftor RE et al. (2008). Emerging roles of nodal and Cripto-1: from embryogenesis to breast cancer progression. Breast Dis 29: 91-103.
48. Sunters A, Fernandez de Mattos S, Stahl M, Brosens JJ, Zoumpou-lidou G, Saunders CA et al. (2003). FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines. J Biol Chem 278: 49795-49805. (Pubitemid 37548813)
49. Tian J, Andree B, Jones CM, Sampath K. (2008). The pro-domain of the zebrafish Nodal-related protein Cyclops regulates its signaling activities. Development 135: 2649-2658.
50. Topczewska JM, Postovit LM, Margaryan NV, Sam A, Hess AR, Wheaton WW et al. (2006). Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness. Nat Med 12: 925-932. (Pubitemid 44175144)
51. Tsai KL, Sun YJ, Huang CY, Yang JY, Hung MC, Hsiao CD. (2007). Crystal structure of the human FOXO3a-DBD/DNA complex suggests the effects of post-translational modification. Nucleic Acids Res 35: 6984-6994.
52. Wang H, Jiang JY, Zhu C, Peng C, Tsang BK. (2006). Role and regulation of nodal/activin receptor-like kinase 7 signaling pathway in the control of ovarian follicular atresia. Mol Endocrinol 20: 2469-2482. (Pubitemid 44496415)
53. Weidinger C, Krause K, Klagge A, Karger S, Fuhrer D. (2008). Forkhead box-O transcription factor: critical conductors of cancer's fate. Endocr Relat Cancer 15: 917-929.
54. Xu G, Bernaudo S, Fu G, Lee DY, Yang BB, Peng C. (2008). Cyclin G2 is degraded through the ubiquitin-proteasome pathway and mediates the antiproliferative effect of activin receptor-like kinase 7. Mol Biol Cell 19: 4968-4979.
55. Xu G, Zhong Y, Munir S, Yang BB, Tsang BK, Peng C. (2004). Nodal induces apoptosis and inhibits proliferation in human epithelial ovarian cancer cells via activin receptor-like kinase 7. J Clin Endocrinol Metab 89: 5523-5534. (Pubitemid 39518436)
56. Xu G, Zhou H, Wang Q, Auersperg N, Peng C. (2006). Activin receptor-like kinase 7 induces apoptosis through up-regulation of Bax and down-regulation of Xiap in normal and malignant ovarian epithelial cell lines. Mol Cancer Res 4: 235-246.
57. Yang JY, Chang CJ, Xia W, Wang Y, Wong KK, Engelman JA et al. (2010). Activation of FOXO3a is sufficient to reverse mitogen-activated protein/extracellular signal-regulated kinase inhibitor chemoresistance in human cancer. Cancer Res 70: 4709-4718.
58. Yang JY, Zong CS, Xia W, Yamaguchi H, Ding Q, Xie X et al. (2008). ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation. Nat Cell Biol 10: 138-148. (Pubitemid 351194043)
59. Ye G, Fu G, Cui S, Zhao S, Bernaudo S, Bai Y et al. (2011). MicroRNA 376c enhances ovarian cancer cell survival by targeting activin receptor-like kinase 7: implications for chemoresistance. J Cell Sci 124: 359-368.
60. You H, Yamamoto K, Mak TW. (2006). Regulation of transactiva-tion- independent proapoptotic activity of p53 by FOXO3a. Proc Natl Acad Sci USA 103: 9051-9056. (Pubitemid 43902531)
61. Zhang N, Kumar M, Xu G, Ju W, Yoon T, Xu E et al. (2006). Activin receptor-like kinase 7 induces apoptosis of pancreatic beta cells and beta cell lines. Diabetologia 49: 506-518. (Pubitemid 43277874)
62. Zhang YQ, Sterling L, Stotland A, Hua H, Kritzik M, Sarvetnick N. (2008). Nodal and lefty signaling regulates the growth of pancreatic cells. Dev Dyn 237: 1255-1267. (Pubitemid 351668811)